Safety And Efficacy Of Exubera Compared With Subcutaneous Human Insulin Therapy In Children And Adolescents

NCT00479258 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Inhaled insulin (Exubera)
DRUG: Subcutaneous Insulin (subject's prescribed)

Sponsor

Pfizer